Trump政府对法院阻止RFK Jr.疫苗接种计划改革的裁决提出上诉
• Trump政府于周三晚间就马萨诸塞州一名联邦法官3月16日的裁决提起上诉,该裁决阻止了卫生部长Robert F. Kennedy Jr.对国家儿童疫苗接种计划的全面改革。 • Brian Murphy法官曾裁定,Kennedy“非法”替换了CDC的疫苗顾问委员会,并搁置了该委员会做出的任何决定。 • 此次上诉表明,尽管其权力面临法律挑战,该政府仍打算继续进行疫苗咨询流程的重组。
kffhealthnews.org由 AI 驱动,附引用来源
Comprehensive coverage and timeline for Vaccine. Aggregated from 19 sources with 33 articles.
33 篇文章 · 19 个来源 · 自 3/13/2026 起的报道
Vaccine 报道随时间的发展情况。
经常与 Vaccine 一起报道的话题。
• Trump政府于周三晚间就马萨诸塞州一名联邦法官3月16日的裁决提起上诉,该裁决阻止了卫生部长Robert F. Kennedy Jr.对国家儿童疫苗接种计划的全面改革。 • Brian Murphy法官曾裁定,Kennedy“非法”替换了CDC的疫苗顾问委员会,并搁置了该委员会做出的任何决定。 • 此次上诉表明,尽管其权力面临法律挑战,该政府仍打算继续进行疫苗咨询流程的重组。
kffhealthnews.org• 参议员 Ron Johnson 和 Robert F. Kennedy Jr. 将联邦政府处理 COVID 起源和疫苗死亡的方式称为一起涉及掩盖行为的“重大丑闻”。 • 他们引用了指向实验室泄漏和未报告的不良事件的新证据。 • 随着公众对卫生机构的信任度下降,这些主张进一步推动了要求开展调查的呼声。
justthenews.com• 康涅狄格州州长 Ned Lamont 于 2026 年 4 月 28 日签署 HB 5044 为法律,扩大了州卫生专员在独立于联邦指南之外发布疫苗建议的权限。 • 该法案包含旨在澄清该州《宗教自由恢复法》(RFRA) 的条款,该法案在立法辩论期间引发了重大争议。 • 该法律还禁止保险公司惩罚治疗拒绝接种疫苗患者的临床医生,从而保护医生的执业自主权。
cidrap.umn.edu• 最近的一项研究表明,在过去的一个季节中,更新的疫苗配方使健康成年人的急诊就诊量和住院率降低了约 50%。 • 这一显著的有效性提升代表了疫苗研发和公共卫生防护策略的一次重大进步。 • 这些发现为美国不断演变的疫苗政策格局提供了支持,具体可见于 CIDRAP 2026 年 4 月 28 日发布的最新疫苗政策状态报告。
cidrap.umn.edu
图片:STAT News• A multiyear international campaign is underway to repair damage to childhood immunization efforts caused by the COVID-19 pandemic. • The initiative focuses on restoring vaccination rates that declined during the pandemic period across multiple countries. • Public health experts view this effort as critical to preventing resurgence of vaccine-preventable diseases in vulnerable pediatric populations.
statnews.com• Health Secretary Robert F. Kennedy Jr., a prominent anti-vaccine voice, praised President Trump's nomination of Dr. Erica Schwartz as CDC Director and expressed his intention to work with her to restore the agency's mission. • Kennedy's public endorsement of the pro-vaccine nominee marked a sharp reversal from his previously hard-line stance on CDC leadership and sparked significant backlash among MAHA (Make America Healthy Again) loyalists online. • The shift comes amid congressional scrutiny of Kennedy's conflicting rhetoric on measles vaccination safety during a Thursday hearing, as measles outbreaks rise across the U.S.
thedailybeast.comSeveral shots – including flu and Covid – lost their CDC recommendations under overhauls from the White HouseSeveral shots lost their recommendation from the US Centers for Disease Control and Prevention (CDC) after a judge’s stay against changes wrought by the Trump administration – which may affect access to the shots in some states. And no new vaccine recommendations may be made as long as the vaccines committee is halted.Access to existing vaccines – and the future development of new vaccines – has been increasingly called into question under the second Trump administration, as the now-halted Advisory Committee on Immunization Practices (ACIP) made controversial recommendations and health officials made unilateral changes to routine vaccines, with long-term and global implications. Continue reading...
theguardian.com
图片:Fred Hutchinson Cancer Center• A Fred Hutch Cancer Center graduate student presented over 25,000 measurements of influenza-fighting antibodies to WHO scientists via videoconference last fall. • The dataset, published in Virus Evolution, offers near real-time tracking of human immune responses to current flu strains, improving seasonal vaccine composition. • This method addresses gaps in traditional surveillance, potentially enhancing vaccine effectiveness against evolving viruses.
fredhutch.orgStudy that reportedly found reduction in ER visits and hospitalizations being reviewed by Jay BhattacharyaA Trump administration appointee has delayed publication of a Centers for Disease Control and Prevention (CDC) report that shows benefits related to the Covid vaccine, leading to concerns that the administration is engaging in behind-the-scenes tactics to undermine vaccines.Research by CDC scientists found that the Covid vaccine cut the likelihood of emergency room visits and hospitalizations for healthy adults last winter by about half, according to reporting from the Washington Post. The acting CDC director, Jay Bhattacharya, reportedly delayed the report’s publication due to concerns surrounding the research’s methodology. Continue reading...
theguardian.com• The FDA granted approval on April 7, 2026, to Moderna's mRESVIA vaccine, an mRNA-based shot targeting respiratory syncytial virus (RSV) for adults aged 60 and older. • Clinical trials showed 83.7% efficacy against RSV lower respiratory tract disease in the first season, with data from over 37,000 participants across 22 countries including US sites. • This marks the second mRNA RSV vaccine approved after GSK's Arexvy, aiming to reduce 140,000-160,000 annual US hospitalizations among seniors; CDC review expected soon.
reuters.com